Omeros announces positive data for human monoclonal antibody OMS721

Omeros has reported positive data using OMS721 in ex vivo studies of endothelial activation relevant to the pathophysiology of human atypical haemolytic uremic syndrome (aHUS), a form of thrombotic microangiopathy (TMA).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news